These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26975904)

  • 1. Monocyte cell membrane-derived nanoghosts for targeted cancer therapy.
    Krishnamurthy S; Gnanasammandhan MK; Xie C; Huang K; Cui MY; Chan JM
    Nanoscale; 2016 Apr; 8(13):6981-5. PubMed ID: 26975904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.
    Wu B; Yu P; Cui C; Wu M; Zhang Y; Liu L; Wang CX; Zhuo RX; Huang SW
    Biomater Sci; 2015 Apr; 3(4):655-64. PubMed ID: 26222425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microfluidic origami chip for synthesis of functionalized polymeric nanoparticles.
    Sun J; Xianyu Y; Li M; Liu W; Zhang L; Liu D; Liu C; Hu G; Jiang X
    Nanoscale; 2013 Jun; 5(12):5262-5. PubMed ID: 23652785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLGA/polymeric liposome for targeted drug and gene co-delivery.
    Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
    Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable Core-Shell Copolymer-Phospholipid Nanoparticles for Combination Chemotherapy: An In Vitro Study.
    Ma W; Xu A; Ying J; Li B; Jin Y
    J Biomed Nanotechnol; 2015 Jul; 11(7):1193-200. PubMed ID: 26307842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
    Saxena V; Naguib Y; Hussain MD
    Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
    Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy.
    Shen JM; Gao FY; Yin T; Zhang HX; Ma M; Yang YJ; Yue F
    Pharmacol Res; 2013 Apr; 70(1):102-15. PubMed ID: 23376353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release.
    Wu J; Kong T; Yeung KW; Shum HC; Cheung KM; Wang L; To MK
    Acta Biomater; 2013 Jul; 9(7):7410-9. PubMed ID: 23535235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
    Misra R; Sahoo SK
    Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
    Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
    Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells.
    Verderio P; Bonetti P; Colombo M; Pandolfi L; Prosperi D
    Biomacromolecules; 2013 Mar; 14(3):672-82. PubMed ID: 23350530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.
    Tabatabaei Mirakabad FS; Akbarzadeh A; Milani M; Zarghami N; Taheri-Anganeh M; Zeighamian V; Badrzadeh F; Rahmati-Yamchi M
    Artif Cells Nanomed Biotechnol; 2016; 44(1):423-30. PubMed ID: 25229832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.